Evidence map›Paper›PMID 40879902›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Respiratory Syncytial Virus Fusion Activity Syncytia Assay.

Kearstin Edmonds, Rebecca Dutch

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kearstin EdmondsDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA.
Rebecca DutchDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY, USA. Rebecca.dutch@uky.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The methods detailed here measure the membrane fusion activity of viral fusion proteins and are optimized for the respiratory syncytial virus (RSV). RSV utilizes a class I fusion protein (F) to facilitate fusion between a viral and cellular membrane to allow viral entry into host cells. This process is carried out with the assistance of the glycoprotein (G), which attaches to the host-cell surface, allowing F to interact with the target cell. The F protein then undergoes conformational changes, which drive membrane fusion, thus creating a path for viral entry. The fusogenic activity of viral fusion proteins can be quantified by observing and measuring syncytia formation via wide-field microscopy. Syncytia are multinucleated cell masses formed by cell-cell membrane fusion, which in this case are driven by viral fusion proteins expressed on the host-cell surface.

Indexed as

Giant CellsRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsViral Fusion ProteinsVirus InternalizationAnimalsCell LineHumansMembrane FusionViral Fusion ProteinsFusion proteinFusogenic activityRespiratory syncytial virus (RSV)SyncytiaWide-field microscopy

Identifiers

PMID40879902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.